PHI received six Phase 1 applications for its next award to be given in late 2010. The submissions, from Brazil, Israel, United States and Sweden, will be reviewed by an expert panel that includes polio survivors to determine which requests will be asked to submit Phase 2 requirements.


September 8, 2009

Call for Proposals for The Research Fund for Post-Poliomyelitis and Neuromuscular Respiratory Research

Deadline for Phase 1 is Friday, March 31, 2010
(to be awarded in 2011).

For criteria and how to submit an application, read the following:

The GINI Research Fund was established in 1995 by the Board of Directors of Gazette International Networking Institute (GINI). Impetus for this decision was a generous bequest from polio survivor Thomas Wallace Rogers. In 2003, GINI changed its name to Post-Polio Health International (PHI), and the fund is now called The Research Fund.

The Research Fund supports the work of researchers investigating the late effects of poliomyelitis and/or neuromuscular respiratory disease through one of two grants:

The Fund's priorities are to provide funds to initiate new research; to continue notable projects; to combine with other resources to complete research into post-poliomyelitis and neuromuscular respiratory research. Applications of all three types, or any combinations thereof, are equally welcomed.

The Research Fund will award its sixth grant in the year 2010, with the funds distributed in 2011.

The postmark deadline for Phase 1 is Wednesday, March 31, 2010.

Send the application in pdf to Joan L. Headley (director@post-polio.org), and one print copy to Post-Polio Health International, 4207 Lindell Boulevard, #110, Saint Louis, MO 63108-2930 USA. Applicants will be notified by Friday, May 21, 2010.

The postmark deadline for Phase 2 is Friday, September 24, 2010.

Applicants will be notified by Friday, December 17, 2010.

One grant for a maximum of $25,000 is available.

A review panel of research experts, health care professionals and persons with disabilities will select a grant recipient.

The Board of Directors of Post-Polio Health International will approve the panel's recommendation.


Criteria for Applicants

Phase 1 (Deadline Wednesday, March 31, 2010; notification Friday, May 21, 2010)

To be considered, applicants should identify which grant they are seeking – The Thomas Wallace Rogers Memorial Respiratory Research Grant or The Post-Poliomyelitis Research Grant – request a specific dollar amount (not to exceed $25,000), and submit a concise concept paper (not to exceed five double-spaced pages) describing the following:

The lead researcher should also send his/her Curriculum Vitae (email preferred) and a letter of support from a high-ranking official of his/her institution/organization, e.g., department head, chief financial officer, president, etc.

A review panel from diverse disciplines will screen the proposals and determine whom to invite to submit a full proposal. Lastly, please submit an additional page that would explain the significance of the work to someone who is not an expert in the field.

Phase 2 (Deadline Friday, September 24, 2010; notification Friday, December 17, 2010)

Applicants who are invited to submit a full proposal must submit the following detailed information:

Any other information requested by the review panel.


Additional contributions are needed to increase the corpus of The Research Fund so larger grants can be awarded.

"Contributing to the Fund is an excellent way to honor loved ones," says Joan Headley, Executive Director of PHI & IVUN.

Tax-deductible donations can be sent to:

Post-Polio Health International (PHI)
4207 Lindell Boulevard, #110, Saint Louis, Missouri 63108-2915 USA

Checks should be made payable to "Post-Polio Health International" (US dollars only).
PHI also accepts VISA, MasterCard and Discover.

Connect here for ways to donate to The Research Fund

To offer "Gifts-in-Kind" sponsorships, or to ask about the needs of PHI, contact Joan L. Headley, Executive Director, at 314-534-0475 or director@post-polio.org.

PHI's Federal I.D. No. 34-0961952

The Research Fund